• Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise

Log in

Start free trial
G2 Intelligence
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
  • Reports
    • Lab Industry Advisor
      • Essentials Reports
      • Premium Reports
      • Elite Reports
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Articles
    • Lab Industry Advisor
    • Clinical Diagnostics Insider
    • Archive
      • Diagnostic Testing and Emerging Technologies
      • Lab Compliance Advisor
      • Laboratory Industry Report
      • National Lab Reporter
  • Webinars
  • Store
Are We in a ‘Quademic’? COVID-19, Flu, RSV, and Norovirus Infections Surge

Are We in a ‘Quademic’? COVID-19, Flu, RSV, and Norovirus Infections Surge

by Pallavi Upadhyay, PhD, CMPP | Mar 14, 2025 | Clinical Diagnostics Insider, Inside the Diagnostics Industry-dtet

The pandemic may have set the stage for a jump in infections from these four nemeses

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Assessing At-Home Testing Accuracy

Assessing At-Home Testing Accuracy

by Oscelle Boye, MBiomed | Jan 20, 2025 | Clinical Diagnostics Insider, Point of Care-dtet

Patients desire direct-to-consumer testing, but are the results this testing provides accurate and reliable?

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’

ProPhase Labs’ Resolution for 2025: Nail Down a ‘Liquidity Event’

by Ron Shinkman | Jan 9, 2025 | Deals-lir, Essential, Lab Industry Advisor

The company has lost nearly $36 million since 2023, but its CEO is aggressively pursuing new revenue options

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
A Lasting Impact: COVID-19 and Cancer Screening

A Lasting Impact: COVID-19 and Cancer Screening

by Michael Schubert, PhD | Dec 17, 2024 | Clinical Diagnostics Insider, Testing Trends-dtet

Several years after the onset of the COVID-19 pandemic, labs are still dealing with the effects of missed and delayed screenings

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
Labs in Court: Two EKRA-Related Cases and Some Usual Suspects

Labs in Court: Two EKRA-Related Cases and Some Usual Suspects

by Danielle Sloane, Morgan Tandy | Oct 28, 2024 | Essential, Lab Industry Advisor, Labs in Court

Recent enforcement actions involved usual targets such as COVID-19, genetic, and urine drug testing, but EKRA also made an appearance

Subscribe to View


Start a Free Trial for immediate access to this article


Try For Free
Already a member? Log in here
« Older Entries

Log In

Join Now | Lost Password?
  • Follow
  • Follow
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
  • Homepage
  • FAQ
  • About Us
  • G2 Intelligence Team
  • Contact Us
  • Privacy Policy
  • Terms
  • Advertise
Copyright © 2025 G2Intelligence.com